Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone in refractory ovarian or primary peritoneal cancer
NCT00025155Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2002
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in ovarian epithelial cancer, primary peritoneal cancer (PPC), sponsored by National Cancer Institute. Started Jul 2002; status: completed.
02
Drugs
ixabepilone
03
Conditions
ovarian epithelial cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00025155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025155.